Clinical Trial Update: Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of ricolinostat for Painful Diabetic Peripheral Neuropathy has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Peripheral Neuropathy

Drugs mentioned

• Ricolinostat (ricolinostat)

Snippet

Sponsor: Regenacy Pharmaceuticals LLC | Conditions: Painful Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2023-09-21